Welcome to
Yilson Development Co., Ltd
Free Member
Yilson Development Co., Ltd
China
Sirolimus Eluting....
-
- Descriptions:
Biodegradable Polymer Coating Proven Safety and Efficacy Profile
*This DES uses a biodegradable polymer coating on the stainless steel stent platform. The proprietary, top-quality coating process allows the integrity of coated polymer after excessive stent expansion and a systemic elution of sirolimus in a well -controlled fashion after the stent implantation. The safety and efficacy of the product is well documented from a related randomized trial in Europe in CTO patients showing low re-stenosis rate and very promising late loss data.
Specifications:
Stent Plaform 316L Stainless Steel
Coating Material PLGA (Biodegradable)
Coating Thickness 4.0±1.0μm
Drug Sirolimus (Rapamycine)
Drug Content 170μg/cm2±20μg/cm2 (12mm,18mm)
150μg/cm2±20μg/cm2 (23mm,28mm,33mm)
Degradation Time >2Months
Clinical Results in 90 Patients with CTO:
Control Group Rapa BMS
6 Month MACE 0% 0%
6 Month TVR 11% 55%
6 Month TLR 4% 19%
6 Month In-Stent Restenosis 16% 61%
6 Month In-Stent Late loss 0.41mm 1.46mm
Available Sizes:
Length 9 12 16 18 20 23 28 33
Diameter
2.50 √ √ √ √ √
2.75 √ √ √ √ √ √
3.00 √ √ √ √ √ √ √ √
3.50 √ √ √ √ √ √ √ √
4.00 √ √ √ √ √ √ √ √
